A phase II trial of azacitidine (NSC-102816) and gemtuzumab ozogamicin (NSC-720568) as induction and post-remission therapy in patients of age 60 and older with previously untreated non-M3 acute myeloid leukemia: SWOG S0703 protocol-Report on the good-risk patients

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Nand, S; Gundacker, H; Godwin, JE; Willman, CL; Norwood, T; Erba, HP; Howard, DS; Coutre, SE; Othus, M; Appelbaum, FR

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • June 1, 2012

Conference End Date

  • June 6, 2012